These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15987950)

  • 41. Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.
    Pipkin JA; Cruz B; Flores RJ; Hinojosa CA; Carcoba LM; Ibarra M; Francis W; Nazarian A; O'Dell LE
    Psychopharmacology (Berl); 2017 May; 234(9-10):1615-1622. PubMed ID: 28342091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facilitation of intracranial self-stimulation behavior in rats by environmental stimuli associated with nicotine.
    Itasaka M; Hanasawa M; Hironaka N; Miyata H; Nakayama K
    Physiol Behav; 2012 Oct; 107(3):277-82. PubMed ID: 22995979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.
    Igari M; Alexander JC; Ji Y; Qi X; Papke RL; Bruijnzeel AW
    Neuropsychopharmacology; 2014 Jan; 39(2):455-65. PubMed ID: 23966067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conditioned facilitation of brain reward function after repeated cocaine administration.
    Kenny PJ; Koob GF; Markou A
    Behav Neurosci; 2003 Oct; 117(5):1103-7. PubMed ID: 14570559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.
    Stoker AK; Olivier B; Markou A
    Psychopharmacology (Berl); 2012 May; 221(2):317-27. PubMed ID: 22147259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.
    Markou A; Paterson NE
    Nicotine Tob Res; 2001 Nov; 3(4):361-73. PubMed ID: 11694204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicotine enhances responding for conditioned reinforcement via α4β2 nicotinic acetylcholine receptors in the ventral tegmental area, but not the nucleus accumbens or the prefrontal cortex.
    Tabbara RI; Fletcher PJ
    Neuropharmacology; 2019 Apr; 148():68-76. PubMed ID: 30550794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice.
    Hilario MR; Turner JR; Blendy JA
    Neuropsychopharmacology; 2012 Nov; 37(12):2661-70. PubMed ID: 22828747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotine-induced enhancement of responding for conditioned reinforcement in rats: role of prior nicotine exposure and α4β2 nicotinic receptors.
    Guy EG; Fletcher PJ
    Psychopharmacology (Berl); 2013 Jan; 225(2):429-40. PubMed ID: 22885874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.
    Stoker AK; Marks MJ; Markou A
    Eur J Pharmacol; 2015 Apr; 753():146-50. PubMed ID: 25107281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.
    Jackson KJ; McIntosh JM; Brunzell DH; Sanjakdar SS; Damaj MI
    J Pharmacol Exp Ther; 2009 Nov; 331(2):547-54. PubMed ID: 19644040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditioned opioid withdrawal decreases nociceptin/orphanin FQ levels in the frontal cortex and olfactory tubercle.
    Walker JR; Terenius L; Koob GF
    Neuropsychopharmacology; 2002 Aug; 27(2):203-11. PubMed ID: 12093594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats.
    O'Dell LE; Torres OV; Natividad LA; Tejeda HA
    Neurotoxicol Teratol; 2007; 29(1):17-22. PubMed ID: 17184972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of oxytocin on nicotine withdrawal in rats.
    Manbeck KE; Shelley D; Schmidt CE; Harris AC
    Pharmacol Biochem Behav; 2014 Jan; 116():84-9. PubMed ID: 24239789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats.
    Markou A; Harrison AA; Chevrette J; Hoyer D
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):133-42. PubMed ID: 15452682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs.
    Lindblom N; de Villiers SH; Semenova S; Kalayanov G; Gordon S; Schilström B; Johansson AM; Markou A; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):182-94. PubMed ID: 16292514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repeated nicotine exposure during adolescence alters reward-related learning in male and female rats.
    Quick SL; Olausson P; Addy NA; Taylor JR
    Behav Brain Res; 2014 Mar; 261():171-6. PubMed ID: 24333376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Animal models of nicotine withdrawal: intracranial self-stimulation and somatic signs of withdrawal.
    Bauzo RM; Bruijnzeel AW
    Methods Mol Biol; 2012; 829():257-68. PubMed ID: 22231819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala.
    Kenny PJ; Chartoff E; Roberto M; Carlezon WA; Markou A
    Neuropsychopharmacology; 2009 Jan; 34(2):266-81. PubMed ID: 18418357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice.
    Jackson AB; Toma W; Contreras KM; Alkhlaif Y; Damaj MI
    Pharmacol Biochem Behav; 2019 Aug; 183():1-5. PubMed ID: 31145916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.